
11
Sep, 2020
World Sepsis Day
The 13th September marks World Sepsis Day. Infectious diseases remains a leading cause of death for children.
11
Sep, 2020
The 13th September marks World Sepsis Day. Infectious diseases remains a leading cause of death for children.
9
Sep, 2020
Penta has been invited to run a one-day session at the Republican Hospital of Infectious Diseases, St Petersburg conference on ‘Actual problems of HIV Infection: Mother and Child’ on Tuesday 15th September. The Penta session What’s new for children and women living with HIV: interactive clinical day with Penta will look at new data on ART in pregnancy and newborns, resistance and recommendations for 1st, 2nd and further lines, supporting our adolescents and coinfections. Register to conference!
7
Sep, 2020
The second trial in neonatal sepsis sponsored by Penta is now in its final stretch towards completion.
3
Sep, 2020
Through 6 distinctive sessions, the WSC Spotlight will give an overview of the global epidemiology and burden of sepsis and AMR, exploring innovative, novel, and cost-effective approaches for the prevention and treatment of both severe infections and antimicrobial resistance.
13
Aug, 2020
Last Patient Last Visit (LPLV) completed for the Penta 17 Strategy for Maintenance of HIV suppression with integrase inhibitor + darunavir/ritonavir in children (SMILE) trial.
6
Aug, 2020
Results from from the ongoing P1093 and ODYSSEY (PENTA20) studies, published in The Lancet HIV journal, show that children over 20kg in weight can safely take adult doses (50mg) of the anti-HIV drug dolutegravir.
29
Jul, 2020
A correspondence by Malte Kohns at St George’s University London to The Lancet Infectious Disease Journal, focusing on the importance of international collaboration.
22
Jul, 2020
20 July 2020
Update webinar by One Health Centre of Excellence
20
Jul, 2020
We are delighted to announce that registrations are now open for our online training course ‘PentaTr@ining 2020: HIV & other Congenital Infections’.
16
Jul, 2020
Paolo Palma and his colleagues recently published in The Lancet HIV the paper “The HIV-1 antibody response: a footprint of the viral reservoir in children vertically infected with HIV”